4//SEC Filing
Fyfe Gwen A. 4
Accession 0001562180-18-004314
CIK 0001100412other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 6:09 PM ET
Size
11.8 KB
Accession
0001562180-18-004314
Insider Transaction Report
Form 4
Fyfe Gwen A.
Director
Transactions
- Exercise/Conversion
Common Stock
2018-10-26+5,000→ 15,000 total - Award
Restricted Stock Units
2018-10-25+5,000→ 5,000 totalExercise: $0.00→ Common Stock (5,000 underlying) - Award
Stock Option (Right to Buy)
2018-10-25+25,000→ 25,000 totalExercise: $14.55Exp: 2028-10-25→ Common Stock (25,000 underlying) - Exercise/Conversion
Restricted Stock Units
2018-10-26−5,000→ 0 totalExercise: $0.00→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by Array BioPharma Inc. ("Array") on October 26, 2017, as a result of the vesting of all such RSUs.
- [F2]The options vest in full on October 25, 2019, subject to continued service on Array's board of directors.
- [F3]RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors.
- [F4]The RSUs vested and were settled in common stock on October 26, 2018.
Documents
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeother
Related Parties
1- filerCIK 0001506217
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 6:09 PM ET
- Size
- 11.8 KB